Acciones Tikun Olam-Cannbit Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Acciones
TKUN
IL0010843675
Farmacéuticos
Ventas 2022 | 49,3 178,44 45,18 | Ventas 2023 | 44,23 160,09 40,54 | Capitalización | 25,49 M 92,26 M 23,36 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -48 M -174 M -43,99 M | Resultado Neto 2023 | -88 M -319 M -80,65 M | VE / Ventas 2022 | 1.234.605 x |
Deuda neta 2022 | 17,5 M 63,35 M 16,04 M | Deuda neta 2023 | 13,42 M 48,57 M 12,3 M | VE / Ventas 2023 | 879.698 x |
P/E ratio 2022 |
-0,97
x | P/E ratio 2023 |
-0,22
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 71,4 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 70 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15/02/15 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,44 % | 3210,86 M | |
+99,85 % | 1873,29 M | |
+286,36 % | 56,06 M |